SUPPRESSA, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 6.511
AS - Asia 2.954
EU - Europa 2.529
SA - Sud America 795
Continente sconosciuto - Info sul continente non disponibili 345
AF - Africa 160
OC - Oceania 3
Totale 13.297
Nazione #
US - Stati Uniti d'America 6.321
SG - Singapore 1.244
IT - Italia 751
BR - Brasile 642
CN - Cina 588
HK - Hong Kong 365
RU - Federazione Russa 363
DE - Germania 296
SE - Svezia 286
VN - Vietnam 245
FR - Francia 181
FI - Finlandia 161
GB - Regno Unito 141
UA - Ucraina 97
BD - Bangladesh 95
IN - India 95
CA - Canada 89
ID - Indonesia 55
MX - Messico 52
NL - Olanda 52
CI - Costa d'Avorio 49
AR - Argentina 38
IQ - Iraq 37
PK - Pakistan 37
JP - Giappone 34
ZA - Sudafrica 33
ES - Italia 32
CO - Colombia 30
TR - Turchia 28
BE - Belgio 27
AT - Austria 24
CL - Cile 24
SA - Arabia Saudita 24
MA - Marocco 22
PL - Polonia 20
IE - Irlanda 18
EC - Ecuador 17
CZ - Repubblica Ceca 16
UZ - Uzbekistan 16
LT - Lituania 15
VE - Venezuela 14
CR - Costa Rica 12
PH - Filippine 12
NP - Nepal 11
JO - Giordania 10
PY - Paraguay 10
TN - Tunisia 10
EG - Egitto 9
MY - Malesia 9
AE - Emirati Arabi Uniti 8
BG - Bulgaria 7
JM - Giamaica 7
KE - Kenya 7
PE - Perù 7
UY - Uruguay 7
DZ - Algeria 6
HN - Honduras 6
KG - Kirghizistan 6
BO - Bolivia 5
BY - Bielorussia 5
ET - Etiopia 5
GR - Grecia 5
PT - Portogallo 5
AZ - Azerbaigian 4
GT - Guatemala 4
IL - Israele 4
PA - Panama 4
SN - Senegal 4
AO - Angola 3
AU - Australia 3
BB - Barbados 3
CH - Svizzera 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
LB - Libano 3
LY - Libia 3
NG - Nigeria 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AL - Albania 2
BH - Bahrain 2
GE - Georgia 2
HR - Croazia 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
QA - Qatar 2
SC - Seychelles 2
SV - El Salvador 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
Totale 12.936
Città #
Ashburn 735
Singapore 631
Fairfield 553
Chandler 484
San Jose 477
Woodbridge 368
Hong Kong 365
Houston 223
Seattle 223
Nyköping 219
Jacksonville 215
Milan 212
Cambridge 192
Beijing 175
Wilmington 174
Council Bluffs 157
New York 145
Ann Arbor 141
Dallas 100
Los Angeles 98
Helsinki 96
Lauterbourg 89
Lawrence 87
Roxbury 84
Rome 76
Santa Clara 67
Bari 62
Boardman 61
Ho Chi Minh City 61
Munich 59
Nanjing 58
Des Moines 53
São Paulo 51
Abidjan 49
Hanoi 47
Columbus 42
Dearborn 42
Brooklyn 41
Jakarta 38
London 37
Buffalo 36
Frankfurt am Main 36
Princeton 35
Inglewood 34
Dong Ket 31
Broomfield 30
Tokyo 30
Nanchang 27
Paris 26
Nuremberg 25
Ostuni 25
San Diego 25
Brussels 24
Chicago 24
Rio de Janeiro 24
Moscow 23
Phoenix 23
Falkenstein 21
San Francisco 20
Toronto 20
Hebei 19
Johannesburg 19
Montreal 19
Shenyang 19
Napoli 18
Amsterdam 17
Chennai 17
Denver 17
Dublin 17
Shanghai 17
Belo Horizonte 16
Turin 16
Mexico City 15
The Dalles 15
Pune 14
Salvador 14
Atlanta 13
Jiaxing 13
Lahore 13
Orem 13
Tashkent 13
Changsha 12
Haiphong 12
Kunming 12
Manchester 12
Taranto 12
Curitiba 11
Tianjin 11
Turku 11
Washington 11
Amman 10
Campinas 10
Charlotte 10
Dhaka 10
Guangzhou 10
Mumbai 10
Warsaw 10
Bogotá 9
Boston 9
Figino 9
Totale 8.161
Nome #
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 238
Real-world efficacy and safety of Inclisiran: a prospective cohort study 227
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 218
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 213
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 209
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation 205
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 192
Asymptomatic microhematuria: an indication of hereditary hemorrhagic telangiectasia? 183
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 183
Capillaroscopy of the dorsal skin of the hands in hereditary hemorrhagic telangiectasia 177
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 177
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 174
Biliary Cystadenoma in a Female Patient with HCV-Related Liver Cirrhosis: A Case Report 173
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 173
"A secret agent" for HHT: asyntomatyc microhematuria 171
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 169
A case of sarcoidosis with isolated hepatosplenic onset and development of inflammatory bowel disease during recovery stage 168
Congenital analbuminemia in a patient affected by hypercholesterolemia: A case report 166
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 165
A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: A questionnaire-based retrospective study 164
Relationship between carotid intima-media thickness and non valvular atrial fibrillation type 160
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 158
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 157
HHT: a rare disease with broad spectrum of clinical aspects 150
The clinical labyrinth of chronic granulomatous diseases: not only sarcoidosis 149
"A secret Weapon" for diagnosis of HHT: the echo-color-Doppler study of the liver 147
Hereditary hemorrhagic telangiectasia: arteriovenous malformations in children. 142
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy 142
AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects 138
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 137
Hepatic angiodynamic profile in paediatric patients with hereditary haemorrhagic telangiectasia type 1 and type 2 135
A new application for capillaroscopy: the study of dorsal surfaces of the hands in HHT 132
Low dose intravenous bevacizumab for the treatment of anaemia in hereditary haemorrhagic telangiectasia. 131
Hereditary Hemorrhagic Telangiectasia: a 15-year shorter life span 125
Neuroimmune activation in chronic heart failure 125
13c-methacetin breath test: a new diagnostic tool for diagnosis of liver involvement in patients affected by hereditary hemorrhagic telangiectasia 123
Identification and surveillance of 19 Lynch syndrome families in southern Italy: report of six novel germline mutations and a common founder mutation 121
Liver involvement in a large cohort of patients with hereditary hemorrhagic telangiectasia: Echo-color-Doppler vs multislice computed tomography study 121
DHPLC-based mutation analysis of ENG and ALK-1 genes in HHT Italian population 120
Abdominal obesity negatively influences key metrics of reverse cholesterol transport 120
Hereditary Hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers 119
Hypogonadotropic hypogonadism associated with hereditary hemorrhagic telangiectasia 116
Monocyte-to-HDL Ratio (MHR) Predicts Vitamin D Deficiency in Healthy and Metabolic Women: A Cross-Sectional Study in 1048 Subjects 116
Orofacial hereditary haemorrhagic telangiectasia: High power diode laser in early and advanced lesion treatment 113
Health-related quality of life in a rare disease: hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease 111
Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia 111
Asymptomatic microhematuria: a spy of Hereditary Hemorrhagic Teleangiectasia (HHT)? 110
Effects of VEGF on phenotypic severity in children with hereditary hemorrhagic telangiectasia 110
Pain and Frailty in Hospitalized Older Adults 109
Diet and myocardial infarction: a nested case-control study in a cohort of elderly subjects in a Mediterranean area of southern Italy 108
Homozygous familial hypercholesterolemia in a young woman with dual gene mutations of low-density lipoprotein receptor and proprotein convertase subtilisin/kexin type 9 107
The arduous challenge of seeking for biomarkers in rare diseases 105
Screening for children from families with Rendu-Osler-Weber disease: from geneticist to clinician 104
Pulmonary Arteriovenous Malformations and Cerebral Abscess Recurrence in a Child With Hereditary Hemorrhagic Telangiectasia. 103
Use of oral anticoagulant drugs in older patients with atrial fibrillation in internal medicine wards 102
Rare diseases in the elderly: a new perspective for the specialist in geriatrics 101
Hereditary hemorrhagic teleangiectasia: a 15-year shorter life span 99
Adipocyte fatty acid-binding protein 4 e iperlipemia familiare combinata 98
Novel approach to idursulfase and laronidase desensitization in type 2 and type 1 S mucopolysaccharidosis (MPS) 97
Diagnostic testing for SARS-CoV-2 infection in HHT patients: nasopharyngeal versus oropharyngeal swab 97
Capillaroscopic Patterns in Patients With HHT 96
The lower is better”: genetic pitfalls of a paradigmatic approach for dyslipidemia 96
Safety of reduced or absent antithrombotic therapy after left atrial appendage closure in patients affected by hereditary hemorrhagic telangiectasia and atrial fibrillation 94
Liver involvement in hereditary hemorrhagic telangiectasia: can breath test unmask impaired hepatic first-pass effect? 94
Thyroid nodule malignancy is associated with increased non-invasive hepatic fibrosis scores in metabolic subjects 93
Sarcoidosis and autoimmunity: In the depth of a complex relationship 92
Improvement of the diagnostic accuracy of the liver shunts in hereditary hemorrhagic teleangiectasia 92
Hyperhomocysteinemia is linked to MASLD 91
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study 89
What changed in the Italian internal medicine and geriatric wards during the lockdown 89
Life expectancy in patients with hereditary haemorrhagic telangiectasia 88
HHT Oro-facial manifestations: histopathological and confocal laser scanning microscopy analysis 87
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study 87
IDENTIFICATION AND VALIDATION OF THE CHRONO MED DIET SCORE: A SURVEY IN 9200 SUBJECTS 86
European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT) 86
Il fenotipo hypertg-waist: impatto sul rischio cardiovascolare e sulla mortalità nella popolazione anziana. 85
Studio longitudinale dell'evoluzione in età evolutiva delle malformazioni arterovenoso nella teleangiectasia emorragica ereditaria 81
COGNITIVE FUNCTIONS, MOOD STATE AND QUALITY OF LIFE IN PATIENTS WITH HHT 81
Involvement of the transforming growth factor beta in the pathogenesis of hereditary hemorrhagic telangiectasia 81
Clinical features of eng- and alk1- mutation carriers 79
Gli ammalati di Teleangiectasia Emorragica Ereditaria vivono in media 15 anni meno rispetto ai loro partners non affetti 79
Association of fT4 and TSH with insulin resistance in aged obese euthyroid people 78
Improvement of the diagnostic accuracy of liver shunts in Hereditary Hemorrhagic Telangiectasia 78
Ultrasonographic analysis of HAVMS in a large cohort of hereditary hemorrhagic telangiectasia patients: definition of a new highly-accurate intrahepatic parameter 78
Characterization of circulating endothelial cells in Hereditary Haemorrhagic Telangiectasia 75
Rapida ed efficiente caratterizzazione di mutazioni in pazienti con Teleangiectasia Emorragica Ereditaria mediante DHPLC 75
Hereditary haemorrhagic telangiectasia: study of hepatic vascular alterations with multi-detector row helical CT and reconstruction programs 75
Multi-slice-ct vs dynamic time-resolved mr-angiography for evaluation of hepatic involvement in hereditary hemorragic telangiectasia 75
Characterization of epidemiological distribution and outcome of COVID-19 in patients with hereditary hemorrhagic telangiectasia: a nationwide retrospective multi-centre study during first wave in Italy 74
Correlazione genotipo-fenotipo nella popolazione italiana affetta da Rendu-Osler-Weber (o Teleangiectasia Emorragica Ereditaria) 73
Dynamic MR-angiography in the evaluation of hepatic involvement in hereditary hemorrhagic telangiectasia 72
null 72
Psycho-social effects regarding the job placement of hereditary hemorrhagic teleangectasia patients 71
Uso dell’angio-RM dinamica nello studio delle alterazioni parenchimali epatiche nei pazienti affetti da HHT: esperienza preliminare 71
Comment on: Atherogenic indices can predict atherosclerosis in patients with sarcoidosis 70
Minimal portosystemic encephalopathy: A new nosological entity in patients with hereditary haemorrhagic telangiectasia 69
Simplex index of insulin resistance in Hereditary Haemorrhagic Telangiectasia (HHT) patients. Preliminary data. 68
Diagnostic delay in rare diseases: the drama of a silent killer 66
The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality care 66
Dynamic 4D MR Angiography vs Multislice CT Angiography in the evaluation of vascular hepatic involvement in Hereditary Hemorragic Teleangiectasia (HHT) 65
Totale 11.831
Categoria #
all - tutte 56.830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.830


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022536 0 0 10 19 45 44 23 32 64 37 103 159
2022/20231.199 151 139 70 113 144 146 15 140 199 6 50 26
2023/2024558 36 95 39 50 49 106 25 59 7 23 18 51
2024/20252.305 94 44 132 84 93 201 248 241 94 125 318 631
2025/20264.911 734 280 313 496 582 289 477 126 544 465 171 434
2026/2027575 140 251 184 0 0 0 0 0 0 0 0 0
Totale 13.297